Amgen Names Jim Daly, Senior Vice President, North America Commercial Operations.THOUSAND OAKS Thousand Oaks, residential city (1990 pop. 104,352), Ventura co., S Calif., in a farm area; inc. 1964. Avocados, citrus, vegetables, strawberries, and nursery products are grown. , Calif. -- Amgen Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :AMGN), the world's largest biotechnology company, today announced the appointment of Jim Daly to the new position of senior vice president, North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. Commercial Operations. Daly, formerly vice president and general manager of the U.S. Oncology Business Unit at Amgen, will be responsible for leading the company's commercial activities in the United States and Canada. Daly will report to George Morrow, executive vice president, Global Commercial Operations. "The newly formed North America Commercial Operations organization, with Jim at the head, will provide better coordination and integration across Amgen's United States and Canada commercial operations as we prepare to launch new therapies emerging from our product pipeline," said Morrow. "Jim brings 20 years of extensive sales, marketing and general management leadership experience to this new position and I anticipate great success for this important part of our business under Jim's guidance." Daly joined Amgen in early 2002 as vice president and general manager, U.S. Oncology Business Unit. In this role, Daly led the successful launches of Aranesp(R) (darbepoetin alfa darbepoetin alfa Aranesp Pharmacologic class: Recombinant human erythropoietin Therapeutic class: Hematopoietic Pregnancy risk category C FDA Boxed Warning), Neulasta(R) (pegfilgrastim) and Kepivance(TM) (palifermin), and was instrumental in establishing their strong market positions. Prior to joining Amgen, Daly spent 17 years at Glaxo Wellcome/GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company)GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) ), where he progressed through positions of increasing responsibility in marketing, including his role as vice president and general manager, Respiratory and Anti-Infectives Business Division at GSK. Daly received his undergraduate degree in Pharmacy and his master's degree in Business Administration from the State University of New York (body) State University of New York - (SUNY) The public university system of New York State, USA, with campuses throughout the state. in Buffalo. About Amgen Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller . |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion